Rothschild & Co Asset Management US’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $6.82M | Sell |
57,111
-7,308
| -11% | -$873K | 0.1% | 152 |
|
|
2022
Q3 | $6.84M | Sell |
64,419
-9,549
| -13% | -$1.01M | 0.12% | 143 |
|
|
2022
Q2 | $7.21M | Sell |
73,968
-4,546
| -6% | -$443K | 0.11% | 150 |
|
|
2022
Q1 | $7.36M | Sell |
78,514
-22,753
| -22% | -$2.13M | 0.09% | 168 |
|
|
2021
Q4 | $8.63M | Buy |
101,267
+12,495
| +14% | +$1.06M | 0.1% | 189 |
|
|
2021
Q3 | $8.51M | Sell |
88,772
-6,932
| -7% | -$665K | 0.11% | 192 |
|
|
2021
Q2 | $9.31M | Sell |
95,704
-10,834
| -10% | -$1.05M | 0.11% | 193 |
|
|
2021
Q1 | $10.4M | Sell |
106,538
-48,152
| -31% | -$4.68M | 0.13% | 192 |
|
|
2020
Q4 | $14.8M | Buy |
154,690
+19,647
| +15% | +$1.88M | 0.19% | 166 |
|
|
2020
Q3 | $13M | Sell |
135,043
-29,208
| -18% | -$2.81M | 0.23% | 171 |
|
|
2020
Q2 | $20M | Sell |
164,251
-45,170
| -22% | -$5.51M | 0.3% | 142 |
|
|
2020
Q1 | $18.1M | Sell |
209,421
-18,399
| -8% | -$1.59M | 0.28% | 139 |
|
|
2019
Q4 | $24.5M | Sell |
227,820
-10,544
| -4% | -$1.13M | 0.25% | 169 |
|
|
2019
Q3 | $21.5M | Buy |
238,364
+28,276
| +13% | +$2.55M | 0.23% | 178 |
|
|
2019
Q2 | $17.7M | Buy |
210,088
+60,013
| +40% | +$5.07M | 0.19% | 199 |
|
|
2019
Q1 | $13.2M | Buy |
150,075
+58,429
| +64% | +$5.15M | 0.14% | 227 |
|
|
2018
Q4 | $6.54M | Buy |
91,646
+24,879
| +37% | +$1.78M | 0.08% | 283 |
|
|
2018
Q3 | $8.21M | Buy |
+66,767
| New | +$8.21M | 0.08% | 281 |
|
|
2018
Q1 | – | Sell |
-26,525
| Closed | -$2.06M | – | 358 |
|
|
2017
Q4 | $2.06M | Sell |
26,525
-11,220
| -30% | -$871K | 0.02% | 316 |
|
|
2017
Q3 | $2.31M | Sell |
37,745
-114
| -0.3% | -$6.99K | 0.03% | 300 |
|
|
2017
Q2 | $1.74M | Sell |
37,859
-2,413
| -6% | -$111K | 0.02% | 334 |
|
|
2017
Q1 | $1.74M | Sell |
40,272
-1,876
| -4% | -$81.2K | 0.02% | 330 |
|
|
2016
Q4 | $1.63M | Buy |
42,148
+34,373
| +442% | +$1.33M | 0.02% | 352 |
|
|
2016
Q3 | $394K | Buy |
7,775
+5
| +0.1% | +$253 | 0.01% | 507 |
|
|
2016
Q2 | $353K | Buy |
+7,770
| New | +$353K | 0.01% | 530 |
|
|
2015
Q3 | – | Sell |
-5,004
| Closed | -$239K | – | 349 |
|
|
2015
Q2 | $239K | Buy |
+5,004
| New | +$239K | ﹤0.01% | 335 |
|